254 related articles for article (PubMed ID: 1685443)
21. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.
Lalwani ND; Reddy MK; Qureshi SA; Reddy JK
Carcinogenesis; 1981; 2(7):645-50. PubMed ID: 7273344
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
Lake BG; Evans JG; Cunninghame ME; Price RJ
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414
[TBL] [Abstract][Full Text] [Related]
23. Increased resistance of peroxisome proliferator-induced hepatic lesions to iron overload in rats.
Rao MS; Subbarao V; Reddy JK
Cancer Lett; 1986 Jul; 32(1):33-9. PubMed ID: 3742486
[TBL] [Abstract][Full Text] [Related]
24. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
Marsman DS; Cattley RC; Conway JG; Popp JA
Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
[TBL] [Abstract][Full Text] [Related]
25. Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nafenopin, a hepatocarcinogenic peroxisome proliferator.
Bieri F; Bentley P; Waechter F; Stäubli W
Carcinogenesis; 1984 Aug; 5(8):1033-9. PubMed ID: 6146407
[TBL] [Abstract][Full Text] [Related]
26. Effects of the hepatocarcinogenic peroxisome-proliferating hypolipidemic agents clofibrate and nafenopin on the rat liver cell membrane enzymes gamma-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesis.
Numoto S; Furukawa K; Furuya K; Williams GM
Carcinogenesis; 1984 Dec; 5(12):1603-11. PubMed ID: 6149819
[TBL] [Abstract][Full Text] [Related]
27. Extraperoxisomal targets of peroxisome proliferators: mitochondrial, microsomal, and cytosolic effects. Implications for health and disease.
Youssef J; Badr M
Crit Rev Toxicol; 1998 Jan; 28(1):1-33. PubMed ID: 9493760
[TBL] [Abstract][Full Text] [Related]
28. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.
Peters JM; Cattley RC; Gonzalez FJ
Carcinogenesis; 1997 Nov; 18(11):2029-33. PubMed ID: 9395198
[TBL] [Abstract][Full Text] [Related]
29. Suppression of choline-deficient diet-induced hepatocyte membrane lipid peroxidation in rats by the peroxisome proliferators 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio(N-beta-hydroxyethyl)- acetamide and di(2-ethylhexyl)phthalate.
Perera MI; Katyal SL; Shinozuka H
Cancer Res; 1986 Jul; 46(7):3304-8. PubMed ID: 3708564
[TBL] [Abstract][Full Text] [Related]
30. Absence of gamma-glutamyl transpeptidase activity in neoplastic lesions induced in the liver of male F-344 rats by di-(2-ethylhexyl)phthalate, a peroxisome proliferator.
Rao MS; Usuda N; Subbarao V; Reddy JK
Carcinogenesis; 1987 Sep; 8(9):1347-50. PubMed ID: 2887302
[TBL] [Abstract][Full Text] [Related]
31. Effects of non-genotoxic hepatocarcinogens phenobarbital and nafenopin on phenotype and growth of different populations of altered foci in rat liver.
Schulte-Hermann R; Kraupp-Grasl B; Bursch W; Gerbracht U; Timmermann-Trosiener I
Toxicol Pathol; 1989; 17(4 Pt 1):642-9; discussion 649-50. PubMed ID: 2576472
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic properties of liver tumors induced by dehydroepiandrosterone in F-344 rats.
Rao MS; Subbarao V; Kumar S; Yeldandi AV; Reddy JK
Jpn J Cancer Res; 1992 Nov; 83(11):1179-83. PubMed ID: 1336491
[TBL] [Abstract][Full Text] [Related]
33. Phthalate esters as peroxisome proliferator carcinogens.
Warren JR; Lalwani ND; Reddy JK
Environ Health Perspect; 1982 Nov; 45():35-40. PubMed ID: 6754363
[TBL] [Abstract][Full Text] [Related]
34. The direct effect of hepatic peroxisome proliferators on rat Leydig cell function in vitro.
Liu RC; Hahn C; Hurtt ME
Fundam Appl Toxicol; 1996 Mar; 30(1):102-8. PubMed ID: 8812244
[TBL] [Abstract][Full Text] [Related]
35. DNA damage related to increased hydrogen peroxide generation by hypolipidemic drug-induced liver peroxisomes.
Fahl WE; Lalwani ND; Watanabe T; Goel SK; Reddy JK
Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7827-30. PubMed ID: 6096860
[TBL] [Abstract][Full Text] [Related]
36. Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators.
Reddy JK; Lalwani ND; Reddy MK; Qureshi SA
Cancer Res; 1982 Jan; 42(1):259-66. PubMed ID: 7053853
[No Abstract] [Full Text] [Related]
37. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.
Issemann I; Green S
Nature; 1990 Oct; 347(6294):645-50. PubMed ID: 2129546
[TBL] [Abstract][Full Text] [Related]
38. Non-genotoxic hepatocarcinogenesis in vitro: the FaO hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis.
Bayly AC; French NJ; Dive C; Roberts RA
J Cell Sci; 1993 Feb; 104 ( Pt 2)():307-15. PubMed ID: 8389374
[TBL] [Abstract][Full Text] [Related]
39. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator.
Kasai H; Okada Y; Nishimura S; Rao MS; Reddy JK
Cancer Res; 1989 May; 49(10):2603-5. PubMed ID: 2713844
[TBL] [Abstract][Full Text] [Related]
40. [Peroxisomes and peroxisome proliferators. Specific environmental poisons and therapeutic agents affecting lipid metabolism and hormone release].
Hammer TA; Waldum HL
Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3603-8. PubMed ID: 9820005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
